Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4588)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 7, 2025 (publication date) through Mar 10, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Abdalla MMI. Gut-liver axis in diabetes: Mechanisms and therapeutic opportunities. World J Gastroenterol 2025; 31(29): 109090 [PMID: 40809928 DOI: 10.3748/wjg.v31.i29.109090] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Abdalla MMI. Gut-liver axis in diabetes: Mechanisms and therapeutic opportunities. World J Gastroenterol 2025; 31(29): 109090 [PMID: 40809928 DOI: 10.3748/wjg.v31.i29.109090] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3249/full/v31/i29/109090.htm |
| Number | Citing Articles |
| 1 |
志君 李. Association between Metabolic Dysfunction-Related Fatty Liver Disease (MASLD) and Colorectal Cancer: A Comprehensive Review of Diagnosis and Disease Progression. Advances in Clinical Medicine 2026; 16(02): 1402 doi: 10.12677/acm.2026.162527
|
| 2 |
The bidirectional relationship between diabetes mellitus and liver disease: Mechanisms, clinical implications, and management strategies. Endocrine 2026; 91(1) doi: 10.1007/s12020-026-04561-3
|
| 3 |
Asmaa. F. Khafaga, Hassan A. Rudayni, Nourhan E. Khalifa, Abdullah S. Alawam, Ahmed A. Allam, Ayman E. Taha, Mohammed A.E. Naiel, Mohamed E. Abd El-Hack. The Gut–Liver Axis in Chronic Liver Diseases: An Integrative Immunopathological Perspective Bridging Animal Models and Human Evidence. Tissue and Cell 2026; : 103456 doi: 10.1016/j.tice.2026.103456
|
| 4 |
Gaoli Zhou, Ronge Xing, Zongji Wang, Rongfeng Li, Song Liu, Hang Li, Guantian Li. Chitosan and chito-oligosaccharides as multifunctional therapeutics for metabolic dysfunction-associated steatotic liver disease (MASLD). Carbohydrate Polymers 2026; 375: 124737 doi: 10.1016/j.carbpol.2025.124737
|
| 5 |
Francesca Uberti, Simone Mulè, Francesca Parini, Matteo Musu, Rebecca Galla. Natural Extract Combination Modulates Intestinal Barrier and Hepatic Cholesterol via the Gut–Liver Axis In Vitro. Pharmaceutics 2026; 18(3): 328 doi: 10.3390/pharmaceutics18030328
|
| 6 |
Da-Yeon Lee, Jing Liu, Gopal Lamichhane, Ashton Swayze, Guolong Zhang, Tae Young Kim, Josephine M. Egan, Yoo Kim. Fermented Red Ginseng Restores Age-Associated Insulin Homeostasis and Gut Microbiome Balance in Mice. Biology 2026; 15(3): 211 doi: 10.3390/biology15030211
|
| 7 |
Almir Fajkić, Yun Wah Lam, Rijad Jahić, Ivan Ćavar, Antonio Markotić, Andrej Belančić. From Adipose Dysfunction to Multi-Organ Steatosis: Defining the Metabolic Steatotic Axis. Current Issues in Molecular Biology 2026; 48(2): 178 doi: 10.3390/cimb48020178
|